Afebrile S. aureus bacteremia in two patients with hemophagocytic lymphohistiocytosis receiving emapalumab/dexamethasone/etoposide-Reference-Cited by-同舟云学术

Afebrile S. aureus bacteremia in two patients with hemophagocytic lymphohistiocytosis receiving emapalumab/dexamethasone/etoposide

Published:2021-03-10 Issue:8 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Singh Jatinder K.¹,Terao Michael A.¹^ORCID,Sarangi Susmita¹,Toth Jennifer¹,Toretsky Jeffrey A.¹²

Affiliation:

1. Division of Pediatric Adolescent and Young Adult Hematology and Oncology Department of Pediatrics, Medstar Georgetown University Hospital Washington District of Columbia USA

2. Department of Oncology, Lombardi Comprehensive Cancer Center Georgetown University Washington District of Columbia USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29001

Reference13 articles.

1. Emapalumab: First Global Approval

2. Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

3. Interferon-γ: an overview of signals, mechanisms and functions

4. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation

5. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful use of emapalumab in refractory hemophagocytic lymphohistiocytosis in a child with Chédiak–Higashi syndrome: a case report;Journal of Medical Case Reports;2023-03-29

2. Multiple drugs;Reactions Weekly;2021-04